← Browse by Condition
Medical Condition

acute leukemias

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT04811560 Phase 1, Phase 2
Recruiting

A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)

Enrollment
400 pts
Location
United States, Austr...
Sponsor
Janssen Research & Development...
View Trial →